Anhui Fengyuan Pharmaceutical Co Ltd
SZSE:000153
Relative Value
The Relative Value of one Anhui Fengyuan Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 6.55 CNY, Anhui Fengyuan Pharmaceutical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Anhui Fengyuan Pharmaceutical Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
A
|
Anhui Fengyuan Pharmaceutical Co Ltd
SZSE:000153
|
3B CNY | 0.7 | 26.7 | 23.3 | 23.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
961.6B USD | 14.8 | 46.6 | 31.4 | 33.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.7B USD | 6.2 | 22 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
292.6B CHF | 4.8 | 31.2 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.9B GBP | 5.5 | 31.8 | 17.5 | 24.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
244B CHF | 5.6 | 22.4 | 13.8 | 17.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.6B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.4 | 9.8 | 11.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.7B USD | 2.5 | 20 | 7.5 | 10 | |
| UK |
|
GSK plc
XETRA:GS71
|
105.9B EUR | 2.8 | 16.1 | 8.1 | 11.5 |